• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

by Truveta Research | Sep 27, 2022 | Research, Research Insights

Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
Disparities in COVID-19 hospitalizations – Part 2: Have COVID-19 hospitalization stays shortened over time?

Disparities in COVID-19 hospitalizations – Part 2: Have COVID-19 hospitalization stays shortened over time?

by Truveta Research | Sep 22, 2022 | Research, Research Insights

Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
Disparities in COVID-19 hospitalizations – Part 1: Who was hospitalized in each wave of the pandemic?

Disparities in COVID-19 hospitalizations – Part 1: Who was hospitalized in each wave of the pandemic?

by Truveta Research | Sep 15, 2022 | Research, Research Insights

COVID-19 impacted communities disproportionately [1]. Especially in the early days of the pandemic, countless reports of inequitable access to treatments and treatment pathways brought to light existing and new disparities in health outcomes [2]. Addressing health...
What we have learned about COVID-19 so far

What we have learned about COVID-19 so far

by Truveta Research | Sep 12, 2022 | Research, Research Insights

At the start of the pandemic, clinicians around the world were struggling for answers. No one knew the best ways to treat patients with COVID-19 infections – when to intubate, which treatments actually work, and more. That’s why more than 20 U.S. health systems have...
Exploring potential connections between COVID infections, long COVID, and mental health

Exploring potential connections between COVID infections, long COVID, and mental health

by Truveta Research | Sep 8, 2022 | Research, Research Insights

The pandemic has fundamentally changed the way we live. For many of us, it has also changed our interactions with the world around us. Previous reports have shown how living through the pandemic has impacted mental health [1,2], including how a COVID-19 diagnosis...
« Older Entries
Next Entries »

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice